This study compares the effect of convalescent plasma vs no convalescent plasma on the outcome of organ support–free days in the hospital among critically ill a
(File photo)
Article continues below advertisement ↴
An international trial tested in over 300 hospitals around the world have concluded that blood thinners improve the outcome for hospitalized COVID-19 patients.
The University of Manitoba released the conclusion of the trials in a media release on Friday.
The introduction of full-dose blood thinners for patients who had mild symptoms of the virus showed a reduced need for organ support.
The release says that three clinical trial platforms spanning five continents in over 300 hospitals have been working together since May 2020 to urgently test whether there is a greater benefit of full doses of heparin (blood thinners) to treat adults hospitalized for non-critical COVID-19 illness compared to the lower dose typically administered to prevent blood clots in hospitalized patients.